BFC Planning’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding LXRX
AG
SL
BFC Planning's LXRX Position: Q3 2026 in Review
BFC Planning sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2026, closing a stake of 1,000 shares — an estimated $2.4K sold.
BFC Planning first reported a position in LXRX in Q2 2026 and held it in 1 quarter. The position peaked at $2.4K in Q2 2026. 112 funds tracked by Wall St. Rank hold LXRX as of Q3 2026.
- BFC Planning reported no remaining Lexicon Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- BFC Planning sold 1,000 Lexicon Pharmaceuticals shares in Q3 2026, an estimated $2.4K.
- BFC Planning first reported a position in Lexicon Pharmaceuticals in Q2 2026 and held it in 1 quarter.
- BFC Planning's Lexicon Pharmaceuticals position peaked at $2.4K in Q2 2026.
- 112 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.